Suppr超能文献

避免药物相互作用——良好处方行为的一个有用指标。

Drug interactions avoided-a useful indicator of good prescribing practice.

作者信息

Williams D, Kelly A, Feely J

机构信息

Departments of Pharmacology and Therapeutics and Community Health and General Practice, Trinity College, Dublin 2, Ireland.

出版信息

Br J Clin Pharmacol. 2000 Apr;49(4):369-72. doi: 10.1046/j.1365-2125.2000.00177.x.

Abstract

AIMS

To develop an index of quality prescribing in general practice by investigating the incidence of potential drug interactions when medicines were coprescribed within the State supported General Medical Services (GMS) in Ireland.

METHODS

We determined an odds ratio (OR), as a measure of the relative risk of being exposed to a potential interaction, comparing the use of the H2-receptor antagonist, cimetidine, with that of the noninteracting agents ranitidine, famotidine and nizatidine in users and nonusers of warfarin, phenytoin and theophylline.

RESULTS AND CONCLUSIONS

In 86 510 prescriptions for the H2-receptor antagonists potentially interacting drugs were dispensed to 8188 (9%) patients in the Eastern Health Board Region of the GMS. We found that prescribers were significantly less likely to use cimetidine (OR = 0.20,95% CI 0. 17-0.21, P < 0.001) in those patients who were coprescribed warfarin, suggesting good prescribing practice within the GMS. Similarly there was preferential use of the noninteracting H2-receptor antagonists in patients receiving phenytoin or theophylline and the extent of this selective prescribing was in keeping with the rank order of severity of interaction with these drugs. This novel pharmacological index may be a sensitive marker of good prescribing practice.

摘要

目的

通过调查爱尔兰国家支持的全科医疗服务(GMS)中联合开具药物时潜在药物相互作用的发生率,制定一个全科医疗质量处方指数。

方法

我们确定了比值比(OR),作为暴露于潜在相互作用相对风险的衡量指标,比较了使用H2受体拮抗剂西咪替丁与使用无相互作用药物雷尼替丁、法莫替丁和尼扎替丁的华法林、苯妥英和茶碱使用者及非使用者。

结果与结论

在GMS东部卫生委员会地区,86510张H2受体拮抗剂处方中,有8188名(9%)患者配到了潜在相互作用药物。我们发现,在联合开具华法林的患者中,开具西咪替丁的处方者明显较少(OR = 0.20,95%CI 0.17 - 0.21,P < 0.001),这表明GMS内的处方行为良好。同样,在接受苯妥英或茶碱的患者中,优先使用无相互作用的H2受体拮抗剂,这种选择性处方的程度与这些药物相互作用严重程度的排序一致。这个新的药理学指数可能是良好处方行为的一个敏感指标。

相似文献

2
Drug interactions of H2-receptor antagonists.H2受体拮抗剂的药物相互作用。
Scand J Gastroenterol Suppl. 1994;206:14-9. doi: 10.3109/00365529409091415.
5
Drug interactions: theory versus practice.
Am J Med. 1984 Nov 19;77(5B):85-9.
6
Therapeutic-interchange program for oral histamine H2-receptor antagonists.
Am J Health Syst Pharm. 1998 Jul 1;55(13):1382-6. doi: 10.1093/ajhp/55.13.1382.
8
Haematological adverse effects of histamine H2-receptor antagonists.组胺H2受体拮抗剂的血液学不良反应。
Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):430-48. doi: 10.1007/BF03259895.

本文引用的文献

3
Relative excess risk: an alternative measure of comparative risk.相对超额风险:一种比较风险的替代度量。
Am J Epidemiol. 1999 Aug 1;150(3):279-82. doi: 10.1093/oxfordjournals.aje.a009999.
7
Development of prescribing indicators for elderly medical inpatients.老年内科住院患者处方指标的制定。
Br J Clin Pharmacol. 1997 Jan;43(1):91-7. doi: 10.1111/j.1365-2125.1997.tb00038.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验